- Supported exchanges /
- KQ /
- 261780.KQ
CHA Vaccine Institute Co. Ltd. (261780 KQ) stock market data APIs
Cha Vaccine Research Institute Co., Ltd., a research-oriented biotechnology company, researches and develops a range of vaccine products targeting infectious and chronic diseases. Its product pipeline includes HBV vaccine that is in Phase IIb planning for the prevention of hepatitis B; Adjuvanted HBV vaccine that is in Phase I/IIa for the treatment of chronic hepatitis B; and VZV Vaccine, which is in pre-clinical planning stage for the prevention of Herpes Zoster. The company also develops influenza vaccine, recombinant MBL, TB vaccine, and cancer vaccine. Cha Vaccine Research Institute Co., Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea.
CHA Vaccine Institute Co. Ltd. Financial Data Overview
| 3725 | |
| 3665 | |
| - | |
| 3740 | |
| 3590 | |
| 3485-6100 | |
| 98 417 M | |
| 26 817 K | |
| 371 M | |
| -69.8713 | |
| 0.701 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
CHA Vaccine Institute Co. Ltd. Fundamental Data is available in our Financial Data APIs
- Net Revenue 371 M
- EBITDA -6 675 643 392
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get CHA Vaccine Institute Co. Ltd. Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get CHA Vaccine Institute Co. Ltd. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
